SwePub
Tyck till om SwePub Sök här!
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Tretli Steinar)
 

Sökning: WFRF:(Tretli Steinar) > Ulmer Hanno > (2020) > The triglyceride-gl...

  • Fritz, JosefMedical University of Innsbruck (författare)

The triglyceride-glucose index as a measure of insulin resistance and risk of obesity-related cancers

  • Artikel/kapitelEngelska2020

Förlag, utgivningsår, omfång ...

  • 2019-04-03
  • Oxford University Press (OUP),2020
  • printrdacarrier

Nummerbeteckningar

  • LIBRIS-ID:oai:DiVA.org:uu-406001
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-406001URI
  • https://doi.org/10.1093/ije/dyz053DOI
  • https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-158777URI
  • https://lup.lub.lu.se/record/7879d8aa-1cdf-4d61-901a-61d746abe3adURI

Kompletterande språkuppgifter

  • Språk:engelska
  • Sammanfattning på:engelska

Ingår i deldatabas

Klassifikation

  • Ämneskategori:ref swepub-contenttype
  • Ämneskategori:art swepub-publicationtype

Anmärkningar

  • BACKGROUND: The role of insulin resistance as a mediator in the association of body mass index (BMI) with site-specific cancer risk has, to our knowledge, never been systematically quantified.METHODS: Altogether 510 471 individuals from six European cohorts, with a mean age of 43.1 years, were included. We used the triglyceride glucose product (TyG index) as a surrogate measure for insulin resistance. We fitted Cox models, adjusted for relevant confounders, to investigate associations of TyG index with 10 common obesity-related cancers, and quantified the proportion of the effect of BMI mediated through TyG index on the log-transformed hazard ratio (HR) scale.RESULTS: During a median follow-up of 17.2 years, 16 052 individuals developed obesity-related cancers. TyG index was associated with the risk of cancers of the kidney HR per one standard deviation increase 1.13, 95% confidence interval: 1.07 to 1.20], liver (1.13, 1.04 to 1.23), pancreas (1.12, 1.06 to 1.19), colon (1.07, 1.03 to 1.10) and rectum (1.09, 1.04 to 1.14). Substantial proportions of the effect of BMI were mediated by TyG index for cancers of the pancreas (42%), rectum (34%) and colon (20%); smaller proportions for kidney (15%) and liver (11%). Little or no mediation was observed for breast (postmenopausal), endometrial and ovarian cancer. Results were similar for males and females, except for pancreatic cancer where the proportions mediated were 20% and 91%, respectively.CONCLUSIONS: The TyG index was associated with increased risk of cancers of the digestive system and substantially mediated the effect of BMI, suggesting that insulin resistance plays a promoting role in the pathogenesis of gastrointestinal cancers.

Ämnesord och genrebeteckningar

Biuppslag (personer, institutioner, konferenser, titlar ...)

  • Bjørge, ToneCancer Registry of Norway, Institute of Population-Based Cancer Research,University of Bergen(Swepub:lu)to1157bj (författare)
  • Nagel, GabrieleUniversity of Ulm (författare)
  • Manjer, JonasLund University,Lunds universitet,Kirurgi,Forskargrupper vid Lunds universitet,Surgery,Lund University Research Groups,Skåne University Hospital(Swepub:lu)smi-jma (författare)
  • Engeland, AndersNorwegian Institute of Public Health,University of Bergen (författare)
  • Häggström, ChristelUppsala University,Umeå University,Umeå universitet,Uppsala universitet,Urologkirurgi,Department of Biobank Research, Umeå University; Department of Public Health and Clinical Medicine, Nutritional Research, Umeå University,Enheten för biobanksforskning,Näringsforskning,Department of Surgical Sciences, Uppsala University, Uppsala, Sweden(Swepub:umu)chlham02 (författare)
  • Concin, HansAgency for Preventive and Social Medicine Vorarlberg (författare)
  • Teleka, StanleyLund University,Lunds universitet,LUCC: Lunds universitets cancercentrum,Övriga starka forskningsmiljöer,Biomarkörer och Epi,Sektion I,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,LUCC: Lund University Cancer Centre,Other Strong Research Environments,Biomarkers and epidemiology,Section I,Department of Clinical Sciences, Lund,Faculty of Medicine(Swepub:lu)st6664te (författare)
  • Tretli, SteinarCancer Registry of Norway, Institute of Population-Based Cancer Research (författare)
  • Gylling, Björn,1978-Umeå University,Umeå universitet,Patologi(Swepub:umu)bjgy0001 (författare)
  • Lang, AloisAgency for Preventive and Social Medicine Vorarlberg (författare)
  • Stattin, PärUppsala University,Umeå universitet,Uppsala universitet,Urologkirurgi,Urologi och andrologi(Swepub:umu)past0003 (författare)
  • Stocks, TanjaLund University,Lunds universitet,Umeå universitet,Urologi och andrologi,LUCC: Lunds universitets cancercentrum,Övriga starka forskningsmiljöer,Biomarkörer och Epi,Sektion I,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,LUCC: Lund University Cancer Centre,Other Strong Research Environments,Biomarkers and epidemiology,Section I,Department of Clinical Sciences, Lund,Faculty of Medicine(Swepub:lu)med-tss (författare)
  • Ulmer, HannoMedical University of Innsbruck (författare)
  • Medical University of InnsbruckCancer Registry of Norway, Institute of Population-Based Cancer Research (creator_code:org_t)

Sammanhörande titlar

  • Ingår i:International Journal of Epidemiology: Oxford University Press (OUP)49:1, s. 193-2040300-57711464-3685

Internetlänk

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy